Pfizer beat third-quarter expectations and raised its 2021 forecast again even as sales of its top product, the COVID-19 vaccine Comirnaty, slipped in the U.S. Soaring international sales of the preventive shots helped pushed total Comirnaty revenue close to $13 billion in the quarter, and the drugmaker said Tuesday that it now expects to book about $36 billion in sales from the vaccine this year
Related posts
-
Police: Substitute teacher faces child pornography charges
A Libertyville man who worked as a substitute teacher faces charges alleging he possessed child pornography,... -
Hoffman Estates native uses archaeology training in search for Americans missing in combat worldwide
Friday is National POW/MIA Recognition Day, but bringing missing Americans home is a year-round focus for... -
Aurora man charged with two felonies after making advances toward ride-share driver
An Aurora man was arrested Wednesday after making sexual advances toward a ride-share driver.